Borderline resectable pancreatic cancer: Prime time for neoadjuvant treatment (oncologist view)
Georg Beyer 1
1 University Hospital LMU Munich
Chairman's Choice, Digestive Oncology, HPB, Pancreas, Radiology & Imaging, Surgery
UEG Week 2022
Login to access library content
Do you need help setting up your myUEG account?
Contact us at [email protected]
New to myUEG?